Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

VYNE Therapeutics (VYNE) Exchange Rate Effect (2019 - 2021)

VYNE Therapeutics' Exchange Rate Effect history spans 3 years, with the latest figure at -$1000.0 for Q2 2021.

  • For Q2 2021, Exchange Rate Effect fell 102.63% year-over-year to -$1000.0; the TTM value through Mar 2022 reached -$1000.0, down 102.56%, while the annual FY2020 figure was $1000.0, 97.56% down from the prior year.
  • Exchange Rate Effect reached -$1000.0 in Q2 2021 per VYNE's latest filing, down from $1000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $38000.0 in Q2 2020 to a low of -$37000.0 in Q1 2020.
  • Average Exchange Rate Effect over 3 years is $5250.0, with a median of $7000.0 recorded in 2019.
  • Peak YoY movement for Exchange Rate Effect: tumbled 384.62% in 2020, then surged 102.7% in 2021.
  • A 3-year view of Exchange Rate Effect shows it stood at $16000.0 in 2019, then soared by 137.5% to $38000.0 in 2020, then tumbled by 102.63% to -$1000.0 in 2021.
  • Per Business Quant, the three most recent readings for VYNE's Exchange Rate Effect are -$1000.0 (Q2 2021), $1000.0 (Q1 2021), and $38000.0 (Q2 2020).